VEGF/VEGFR inhibitors

GS UHL Pill - yellow capsule-shape

Generic Name: pazopanib

Pill with imprint GS UHL is Yellow, Capsule-shape and has been identified as Votrient pazopanib 400 mg. It is supplied by GlaxoSmithKline.

Votrient is used in the treatment of Soft Tissue Sarcoma; Renal Cell Carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Votrient (Pazopanib [ paz-oh-pa-nib ])-GS UHL-pazopanib 400 mg-Yellow-Capsule-shape

Votrient
Generic Name: pazopanib [ paz-oh-pa-nib ]
Imprint: GS UHL
Strength: pazopanib 400 mg
Color: Yellow
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients:
Latest News
Related Drugs